RENAISSANCE TECHNOLOGIES LLCRENAISSANCE TECHNOLOGIES LLC

Institutional investor · Portfolio as of Q2 2024

Top Holdings3,444 positions

Checking export access…
Activity:
NVONVO
ADR

NOVO-NORDISK A/S ADR

9.2M$1.3B2.2%$24.95+428.35%
19 qtrssince 2019-Q4
Decreased
0

Palantir Technologies Inc

39.5M$1B1.7%$13.82+83.30%
13 qtrssince 2021-Q2
Decreased
0

NVIDIA Corp

7M$867.5M1.5%$60.89+102.34%
6 qtrssince 2023-Q1
Increased
81

Vertex Pharmaceuticals Inc

1.6M$734.2M1.2%$263.22+78.07%
19 qtrssince 2019-Q4
Decreased
0

United Therapeutics Corp

2.2M$692.7M1.2%$97.02+228.34%
19 qtrssince 2019-Q4
Increased
50

VeriSign Inc

3M$538.3M0.9%$191.21-7.82%
19 qtrssince 2019-Q4
Decreased
0

Facebook Inc

1M$527.5M0.9%$345.04+45.05%
12 qtrssince 2021-Q3
Decreased
0

Airbnb Inc

3.4M$515.8M0.9%$122.77+23.51%
13 qtrssince 2021-Q2
Decreased
0

Broadcom Inc

294,115$472.2M0.8%$157.590.00%
1 qtr
New
61

Tesla Inc

2.1M$405.9M0.7%$214.62-7.80%
19 qtrssince 2019-Q4
Increased
50

Sprouts Farmers Market Inc

4.4M$371.3M0.6%$29.69+181.75%
19 qtrssince 2019-Q4
Increased
50

Franco-Nevada Corp

3.1M$364.3M0.6%$105.87+10.75%
19 qtrssince 2019-Q4
Decreased
0

Apple Inc

1.7M$362.6M0.6%$204.40+2.07%
16 qtrssince 2020-Q3
Increased
71

Gilead Sciences Inc

5.1M$347M0.6%$57.37+12.29%
19 qtrssince 2019-Q4
Increased
51

Exelixis Inc

15.2M$340.7M0.6%$18.79+19.60%
19 qtrssince 2019-Q4
Increased
44

Neurocrine Biosciences Inc

2.5M$339.8M0.6%$116.50+18.17%
19 qtrssince 2019-Q4
Increased
48

CBOE Holdings Inc

1.9M$318.8M0.5%$111.33+50.28%
19 qtrssince 2019-Q4
Decreased
0

Chipotle Mexican Grill Inc

5.1M$318.1M0.5%$44.69+40.18%
9 qtrssince 2022-Q2
Increased
70

Incyte Corp

5.2M$316.3M0.5%$81.21-25.35%
19 qtrssince 2019-Q4
Decreased
0

DoorDash Inc

2.8M$303.3M0.5%$92.11+18.10%
13 qtrssince 2021-Q2
Increased
50
$59B
AUM
3,444
Positions
Q2 2024
Filing
HI score · 2.5/5
Quarterly 13F Value Change
+3%Q1'23$75.4B-8%Q2'23$69.4B-15%Q3'23$58.7B+10%Q4'23$64.6B-2%Q1'24$63.6B-7%Q2'24$59B
Activity profile
$ moved · Q2'24
New16%Increased27%Decreased40%Exited17%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.4 years
<1Q3%1-4Q7%1-2Y7%2Y+83%

RENAISSANCE TECHNOLOGIES LLC manages $59B across 3444 positions as of Q2 2024. Top holdings: NVO (2.2%), PLTR (1.7%), NVDA (1.5%). Fund DNA: Diversified Scout. HoldingsIntel Score: 2.5/5.0.

Q2 2024 Summary

Active quarter - 496 new positions, 711 exits, 1432 increased. Top move: NVDA (INCREASED, conviction 81). Portfolio: $59.0B across 3444 positions.

Top holdings by portfolio weight

Total AUM$59B
NVO2.22%
PLTR1.70%
NVDA1.47%
VRTX1.25%
UTHR1.18%
VRSN0.91%
META0.89%
ABNB0.87%
AVGO0.80%
TSLA0.69%
Other0.63%

Portfolio allocation by GICS sector

Sectors11
Technology19.03%
Healthcare17.95%
Consumer Cyclical13.59%
Industrials8.46%
Unknown7.89%
Financial Services7.53%
Consumer Defensive6.99%
Communication Services5.68%
Basic Materials4.55%
Energy4.32%
Other4.00%

Behavioral investing profile

Checking access…
Diversified Scout- primarily Technology, Healthcare, Consumer Cyclical
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(2.5 / 5.0)
Holdings P&L44
Conviction36
Concentration18
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
ACRVACRVACRIVON THERAPEUTICS INC
Q4 2024 → Q2 2026+712,963 shares+$1M
7Q
CHGGCHGGCHEGG INC
Q4 2024 → Q2 2026+2M shares+$936,762
7Q
CRCTCRCTCRICUT INC COM CL A
Q4 2024 → Q2 2026+333,411 shares+$57,703
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used